Ali Bader Khamail, Maatook Majid A, Zaboon Ibrahim A
Department of Community Health Techniques, College of Health & Medical Technologies, Basrah, Southern Technical University.
Al-Faiha Specialized Diabetes, Endocrine and Metabolism Center, Al-Basra Health Directorate, Ministry of Health, Iraq.
J Public Health Afr. 2023 Aug 3;14(8):2766. doi: 10.4081/jphia.2023.2766. eCollection 2023 Aug 7.
Metabolic syndrome (MetS) is a collection of cardiovascular risk factors induced by insulin resistance and an inflammatory state that increases the likelihood of developing type 2 diabetes and a variety of cardiovascular disorders.
The study aims to determine the distribution of MetS by diagnostic criteria and family history among adults in Al- Basra province, southern Iraq.
A cross-sectional study was conducted at the Al- Fiaha Specialized Diabetes, Endocrine, and Metabolism Center (FDEMC) from October 2, 2022, to May 1, 2023. Following ethical approval, data was obtained using a pre-tested questionnaire. All patient information was obtained from direct interviews as well as FDEMC's digital records, which controlled patient data via a Microsoft Access program and an internal network.
This study included 476 people, aged 19 to 89. The sample had an equal number of males and females (238). MetS was identified in 247 people in the entire sample using the International Diabetes Federation criteria. The proportion of participants with a family history was as follows: obesity (30.0%), hypertension (44.1%), diabetes mellitus (46.6%), and cardiovascular disease (9.3%). The diagnostic criteria for MetS were as follows: high wc (94.3%), elevated glucose (69.6%), reduced highdensity lipoprotein (HDL) (80.2%), elevated TG (40.5%), and hypertension (71.7%). Controlled on glycemic status (21.1%), hypertension (61.9%), and lipids (44.1%).
Large wc, reduced HDL, and family histories of obesity, hypertension, diabetes mellitus, or cardiovascular disease are the most important risk factors for MetS. Participants with MetS have difficulties controlling their blood sugar, but they regulate the other MetS components.
代谢综合征（MetS）是由胰岛素抵抗和炎症状态引发的一系列心血管危险因素，会增加患2型糖尿病和多种心血管疾病的可能性。
本研究旨在确定伊拉克南部巴士拉省成年人中按诊断标准和家族史划分的代谢综合征分布情况。
于2022年10月2日至2023年5月1日在费亚哈糖尿病、内分泌和代谢专科中心（FDEMC）开展了一项横断面研究。在获得伦理批准后，使用预先测试的问卷获取数据。所有患者信息均通过直接访谈以及FDEMC的数字记录获得，该中心通过Microsoft Access程序和内部网络对患者数据进行管理。
本研究纳入了476人，年龄在19至89岁之间。样本中男性和女性数量相等（各238人）。根据国际糖尿病联盟标准，整个样本中有247人被诊断为代谢综合征。有家族病史的参与者比例如下：肥胖（30.0%）、高血压（44.1%）、糖尿病（46.6%）和心血管疾病（9.3%）。代谢综合征的诊断标准如下：腰围高（94.3%）、血糖升高（69.6%）、高密度脂蛋白（HDL）降低（80.2%）、甘油三酯升高（40.5%）和高血压（71.7%）。血糖状态得到控制的比例为21.1%，高血压为61.9%，血脂为44.1%。
腰围大、高密度脂蛋白降低以及肥胖、高血压、糖尿病或心血管疾病的家族史是代谢综合征最重要的危险因素。患有代谢综合征的参与者在控制血糖方面存在困难，但他们能调节代谢综合征的其他组成部分。
